xpeer logo
© Xpeer 2026 All rights reserved
Privacy Policy - Terms of Use - Help

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Diabetes in CKD and other vulnerable populations

4.9

Accredited (Credits: 1)
Free
1h 15min
Audio: German +4
Subtitles: German +4

Synopsis

In this course you will find an overview of the epidemiology and characteristics of the common association between diabetes and chronic kidney disease, as well as particularities of diabetes in other vulnerable populations, and screening objectives to prevent the morbimortality related to these conditions. This activity is supported by an independent support grant from Sanofi

Accreditation

This course is accredited with 1 ECMEC credit valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.

See more information on the accreditation at: Accreditation

Duration

1h 15min

Target audience

Endocrinology, Nephrology, Internal medicine, General practice, Geriatrics

Authors

Prof Dr Michel Jadoul

Professor Michel Jadoul, MD, Head of the nephrology department at Cliniques Universitaires Saint-Luc, and Professor at Université Catholique de Louvain (UCL). He is co-chair of the Executive Committee of Kidney Disease: Improving Global Outcomes (KDIGO).

Conflicts of interests statement:

Professor Jadoul reports receiving grants or research support from Astra-Zeneca, receiving honoraria or consultation fees from Astellas, Astra-Zeneca, Bayer, Boehringer-Ingelheim, Cardiorenal, CSL Vifor, GSK, Stada-Eurogenerics, and Vertex, participating in speaker’s bureaus sponsored by Astra-Zeneca, Bayer, Boehringer-Ingelheim, and Vertex, and being cochair of Kidney Disease: Improving Global Outcomes (KDIGO) since January 2019.

Testimonials

“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.”

Francisco P. onTrustpilot

Spain

“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.”

Omar I. onTrustpilot

Spain

“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.”

Wil A. onTrustpilot

Netherlands

Read more reviews onTrustpilot

FAQs

What you will learn

Before you begin

  • Pre-course assessment: please complete to help us personalise your learning experience

Trailer

  • Trailer

Diabetes in CKD and other vulnerable populations

  • Introduction
  • Definitions of diabetes and Chronic Kidney Disease (CKD)
  • Epidemiology of diabetes, of CKD and their association
  • Diabetic Nephropathy versus Diabetic Kidney Disease (DKD)
  • Pathophysiology and risk factors for DKD
  • Complications and burden of DKD
  • Screening for CKD in diabetes
  • Conclusions

Accreditation - Evaluation

  • Satisfaction survey
  • Multiple-choice test

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account